{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:29:13Z","timestamp":1791192553424,"version":"4.1.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8,15]]},"DOI":"10.1093\/cid\/cis473","type":"journal-article","created":{"date-parts":[[2012,5,10]],"date-time":"2012-05-10T06:34:50Z","timestamp":1336631690000},"page":"534-542","source":"Crossref","is-referenced-by-count":104,"title":["Increased Susceptibility of Pseudomonas aeruginosa to Macrolides and Ketolides in Eukaryotic Cell Culture Media and Biological Fluids Due to Decreased Expression of oprM and Increased Outer-Membrane Permeability"],"prefix":"10.1093","volume":"55","author":[{"given":"Julien M.","family":"Buyck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Pl\u00e9siat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Traore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Vanderbist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Tulkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Van Bambeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,5,9]]},"reference":[{"key":"key\n\t\t\t\t20170522094603_CIS473C1","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1469-0691.2007.01681.x","article-title":"Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium","volume":"13","author":"Mesaros","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20170522094603_CIS473C2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1128\/AAC.21.2.299","article-title":"Outer membrane permeability in Pseudomonas aeruginosa: comparison of a wild-type with an antibiotic-supersusceptible mutant","volume":"21","author":"Angus","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170522094603_CIS473C3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1568026013395605","article-title":"Multidrug efflux in Pseudomonas aeruginosa: components, mechanisms and clinical significance","volume":"1","author":"Poole","year":"2001","journal-title":"Curr Top Med Chem"},{"key":"key\n\t\t\t\t20170522094603_CIS473C4","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/infdis\/155.4.775","article-title":"Beta-lactamase lability and inducer power of newer beta-lactam antibiotics in relation to their activity against beta-lactamase-inducibility mutants of Pseudomonas aeruginosa","volume":"155","author":"Livermore","year":"1987","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170522094603_CIS473C5","article-title":"Performance standards for antimicrobial susceptibility testing","year":"2010"},{"key":"key\n\t\t\t\t20170522094603_CIS473C6","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/jac\/dkr040","article-title":"Effectiveness and safety of macrolides in cystic fibrosis patients: a meta-analysis and systematic review","volume":"66","author":"Cai","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170522094603_CIS473C7","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/ppul.21315","article-title":"Trends in the use of routine therapies in cystic fibrosis: 1995\u20132005","volume":"45","author":"Konstan","year":"2010","journal-title":"Pediatr Pulmonol"},{"key":"key\n\t\t\t\t20170522094603_CIS473C8","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.prrv.2009.12.003","article-title":"The role of azithromycin in patients with cystic fibrosis","volume":"11","author":"Yousef","year":"2010","journal-title":"Paediatr Respir Rev"},{"issue":"Suppl B","key":"key\n\t\t\t\t20170522094603_CIS473C9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/jac\/41.suppl_2.37","article-title":"Anti-inflammatory activity of macrolides: a new therapeutic potential?","volume":"41","author":"Labro","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170522094603_CIS473C10","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1128\/AAC.50.5.1680-1688.2006","article-title":"Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: a global approach","volume":"50","author":"Nalca","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170522094603_CIS473C11","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1128\/AAC.49.4.1377-1380.2005","article-title":"Azithromycin exhibits bactericidal effects on Pseudomonas aeruginosa through interaction with the outer membrane","volume":"49","author":"Imamura","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170522094603_CIS473C12","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1128\/AAC.48.6.2251-2259.2004","article-title":"Effect of erythromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model","volume":"48","author":"Nagata","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170522094603_CIS473C13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1128\/AAC.45.1.105-116.2001","article-title":"Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy","volume":"45","author":"Lomovskaya","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170522094603_CIS473C14","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1128\/AAC.47.7.2283-2292.2003","article-title":"Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages","volume":"47","author":"Seral","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170522094603_CIS473C15","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1128\/AAC.6.4.442","article-title":"Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa","volume":"6","author":"Kluge","year":"1974","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170522094603_CIS473C16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1021\/jm900615h","article-title":"Synthesis and antimicrobial evaluation of amphiphilic neamine derivatives","volume":"53","author":"Baussanne","year":"2010","journal-title":"J Med Chem"},{"key":"key\n\t\t\t\t20170522094603_CIS473C17","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/jac\/dkl504","article-title":"A combined phenotypic and genotypic method for the detection of Mex efflux pumps in Pseudomonas aeruginosa","volume":"59","author":"Mesaros","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170522094603_CIS473C18","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/jac\/dkp185","article-title":"Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype","volume":"64","author":"Wolter","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170522094603_CIS473C19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1365-2672.2000.00971.x","article-title":"Fluorometric assessment of gram-negative bacterial permeabilization","volume":"88","author":"Helander","year":"2000","journal-title":"J Appl Microbiol"},{"key":"key\n\t\t\t\t20170522094603_CIS473C20","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/AAC.26.4.546","article-title":"Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa","volume":"26","author":"Loh","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170522094603_CIS473C21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1368-7646(98)80023-X","article-title":"The role of outer membrane and efflux pumps in the resistance of gram-negative bacteria. Can we improve drug access?","volume":"1","author":"Nikaido","year":"1998","journal-title":"Drug Resist Updat"},{"key":"key\n\t\t\t\t20170522094603_CIS473C22","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1128\/AAC.19.5.777","article-title":"Involvement of the outer membrane in gentamicin and streptomycin uptake and killing in Pseudomonas aeruginosa","volume":"19","author":"Hancock","year":"1981","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170522094603_CIS473C23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2323\/jgam.52.295","article-title":"Low-frequency ultrasound increases outer membrane permeability of Pseudomonas aeruginosa","volume":"52","author":"Runyan","year":"2006","journal-title":"J Gen Appl Microbiol"},{"key":"key\n\t\t\t\t20170522094603_CIS473C24","first-page":"233","article-title":"Studies on the mechanism of action of colistin. II. Alteration of permeability of Escherichia coli by colistin","volume":"8","author":"Nakajima","year":"1965","journal-title":"Biken J"},{"key":"key\n\t\t\t\t20170522094603_CIS473C25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6968.2002.tb11448.x","article-title":"Antibacterial properties of cationic steroid antibiotics","volume":"217","author":"Savage","year":"2002","journal-title":"FEMS Microbiol Lett"},{"key":"key\n\t\t\t\t20170522094603_CIS473C26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1128\/JB.114.1.399-407.1973","article-title":"Proteins released from cell envelopes of Pseudomonas aeruginosa on exposure to ethylenediaminetetraacetate: comparison with dimethylformamide-extractable proteins","volume":"114","author":"Stinnett","year":"1973","journal-title":"J Bacteriol"},{"key":"key\n\t\t\t\t20170522094603_CIS473C27","first-page":"267","article-title":"Principles of anti-infective therapy","volume-title":"Principles and practice of infectious diseases","author":"Pillai","year":"2010"},{"key":"key\n\t\t\t\t20170522094603_CIS473C28","first-page":"48","article-title":"Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions","volume":"2","author":"Schweizer","year":"2003","journal-title":"Genet Mol Res"},{"key":"key\n\t\t\t\t20170522094603_CIS473C29","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1128\/AAC.44.3.658-664.2000","article-title":"Assignment of the substrate-selective subunits of the MexEF-OprN multidrug efflux pump of Pseudomonas aeruginosa","volume":"44","author":"Maseda","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170522094603_CIS473C30","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1128\/AAC.44.12.3322-3327.2000","article-title":"Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa","volume":"44","author":"Masuda","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170522094603_CIS473C31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s101560050042","article-title":"Potential of macrolide antibiotics to inhibit protein synthesis of Pseudomonas aeruginosa: suppression of virulence factors and stress response","volume":"6","author":"Tateda","year":"2000","journal-title":"J Infect Chemother"},{"key":"key\n\t\t\t\t20170522094603_CIS473C32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ab.2008.10.041","article-title":"Development of a liquid chromatography\/mass spectrometry-based drug accumulation assay in Pseudomonas aeruginosa","volume":"385","author":"Cai","year":"2009","journal-title":"Anal Biochem"},{"issue":"Suppl A","key":"key\n\t\t\t\t20170522094603_CIS473C33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jac\/25.suppl_A.73","article-title":"The pharmacokinetics of azithromycin in human serum and tissues","volume":"25","author":"Foulds","year":"1990","journal-title":"J Antimicrob Chemother"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/55\/4\/534\/17350324\/cis473.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T11:16:10Z","timestamp":1594120570000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1093\/cid\/cis473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,9]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,5,9]]},"published-print":{"date-parts":[[2012,8,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cis473","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5,9]]}}}